HSBC Holdings’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-50,000
Closed -$461K – 3258
2024
Q4
$461K Buy
+50,000
New +$483K ﹤0.01% 2233
2022
Q1
– Sell
-33,700
Closed -$3.14M – 3478
2021
Q4
$3.14M Sell
33,700
-8,300
-20% -$992K ﹤0.01% 1479
2021
Q3
$5.36M Buy
42,000
+1,800
+4% +$262K 0.01% 1122
2021
Q2
$6.72M Buy
+40,200
New +$6.51M 0.01% 986

Other funds holding TDOC

HSBC Holdings's TDOC Position: Q2 2026 in Review

HSBC Holdings sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 30,956 shares — an estimated $162K sold.

HSBC Holdings first reported a position in TDOC in Q1 2017 and held it in 29 quarters. The position peaked at $14.1M in Q4 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • HSBC Holdings reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 30,956 Teladoc Health shares in Q2 2026, an estimated $162K.
  • HSBC Holdings first reported a position in Teladoc Health in Q1 2017 and held it in 29 quarters.
  • HSBC Holdings's Teladoc Health position peaked at $14.1M in Q4 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.